Episode 21
#21 - Simon Allen, Former CEO of Anebulo Pharmaceuticals
October 25, 202313m 56s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Simon Allen, Former CEO, Anebulo Pharmaceuticals
What you'll get out of this episode:
- Journey from biochemistry to sell-side biotech business development.
- Current treatment landscape for ACI and the limitations therein.
- Introduction to ANEB-001, a promising antidote aimed at the CB1 receptor to counter cannabinoid overload.
- Impact of synthetic cannabinoids and the silent peril they pose.
- Upcoming milestones: Finalization of Phase 2 data and optimistic outlook towards FDA outcomes.
*Since the recording of this episode Simon has moved onto new endeavors*
To learn more about Anebulo Pharmaceuticals: https://www.anebulo.com/
Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/